I. Fukui

发表

Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.

Kazutaka Saito, Kazunori Kihara, Noboru Numao, 2008, European urology.

The processus vaginalis transection method to prevent postradical prostatectomy inguinal hernia: long-term results.

K. Kihara, Y. Fujii, S. Urakami, 2014, Urology.

Performance of prostate‐specific antigen mass in estimation of prostate volume in Japanese men with benign prostate hyperplasia

K. Kihara, F. Koga, Kazutaka Saito, 2012, International journal of urology : official journal of the Japanese Urological Association.

Incidence and Predictors of Deep Vein Thrombosis in Patients with Elevated Serum D-Dimer Prior to Surgery for Urologic Malignancy

N. Numao, Shinya Yamamoto, J. Yonese, 2019, Urologia Internationalis.

Cellular senescence of a human bladder carcinoma cell line (JTC-32) induced by a normal chromosome 11.

M. Oshimura, K. Kihara, T. Schulz, 2000, Cancer genetics and cytogenetics.

Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report

S. Uehara, Shinya Yamamoto, J. Yonese, 2016, Molecular and clinical oncology.

Patient‐reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial

Y. Ohashi, A. Yokomizo, S. Naito, 2021, Cancer medicine.

Oncological outcomes for patients with locally advanced prostate cancer treated with neoadjuvant endocrine and external-beam radiation therapy followed by adjuvant continuous/intermittent endocrine therapy in an open-label, randomized, phase 3 trial.

Y. Ohashi, A. Yokomizo, S. Naito, 2020, Cancer.

Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer

Y. Ishikawa, K. Kihara, J. Kumagai, 2012, BJU international.

Clinical outcome of urachal cancer in Japanese patients

Y. Fujii, S. Uehara, Tatsuro Hayashi, 2016, International Journal of Clinical Oncology.

Impact of lower urinary tract symptoms on prostate cancer risk among Japanese men with prostate‐specific antigen <10 ng/mL and non‐suspicious digital rectal examination

K. Kihara, F. Koga, Y. Fujii, 2013, International journal of urology : official journal of the Japanese Urological Association.

Characteristics and clinical significance of prostate cancers missed by initial transrectal 12‐core biopsy

Y. Ishikawa, K. Kihara, S. Yoshida, 2012, BJU international.

Clinical Significance of “Cannibalism” in Urinary Cytology of Bladder Cancer

I. Fukui, H. Ohshima, Shin‐ichi Kojima, 1998, Acta Cytologica.

Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib

T. Habuchi, N. Tsuchiya, M. Saito*, 2012, BJU international.

Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function

S. Kimura, T. Habuchi, N. Tsuchiya, 2012, International journal of cancer.

Preliminary report of multimodal treatment with ifosfamide, 5‐fluorouracil, etoposide and cisplatin (IFEP chemotherapy) against metastatic adenocarcinoma of the urachus

Y. Ishikawa, Y. Fujii, S. Kawakami, 2008, International journal of urology : official journal of the Japanese Urological Association.

Late Recurrence and Progression after a Long Tumor-Free Period in Primary Ta and T1 Bladder Cancer

K. Kihara, T. Tsujii, Y. Fujii, 1999, European Urology.

Patient-perceived satisfaction after definitive treatment for men with high-risk prostate cancer: radical prostatectomy vs. intensity-modulated radiotherapy with androgen deprivation therapy.

Y. Fujii, S. Urakami, Shinya Yamamoto, 2015, Urology.

Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer

Y. Fujii, S. Uehara, A. Yano, 2015, BMC Research Notes.

Outcome of Antegrade Radical Prostatectomy with Intended Wide Resection in Prostate Cancer Patients with a Preoperative Serum PSA Level >100 ng/ml

Y. Ishikawa, S. Urakami, Y. Yasuda, 2011, Urologia Internationalis.

Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease

Y. Ishikawa, T. Kijima, Y. Fujii, 2010, International journal of urology : official journal of the Japanese Urological Association.

Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients.

T. Habuchi, N. Tsuchiya, Shinya Yamamoto, 2010, Urology.

Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab

Y. Fujii, S. Uehara, Shinya Yamamoto, 2016, International Journal of Clinical Oncology.

Subject Index, Volume 42, 1998

G. Nilsson, O. Larsson, M. Tsou, 1998, Acta Cytologica.

Contributor Index, Volume 42, 1998

G. Nilsson, O. Larsson, M. Tsou, 1998, Acta Cytologica.

[Successful management for chemorefractory testicular cancer with brain and lung metastases. A case report].

S. Okumura, J. Yonese, I. Fukui, 1998, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Diabetes mellitus in Asia : ecological aspects of epidemiology, complications and treatment : proceedings of the second symposium, Kyoto, Japan, September 9-11, 1975

I. Fukui, Y. Gotō, S. Baba, 1976 .

Clinical efficacy of BAY g 5421 (acarbose) in noninsulin- dependent diabetes mellitus (NIDDM) — a placebo-controlled double-blind comparative study

H. Orimo, S. Tarui, I. Fukui, 1992 .

[Intra-arterial CDDP and CDDP plus THP-ADM therapy for bladder cancer].

K. Kihara, I. Fukui, S. Kitahara, 1993, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Adjuvant chemotherapy for invasive bladder cancer. Multicenter study].

K. Kihara, I. Fukui, H. Oshima, 1992, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.

Y. Ishikawa, S. Kawakami, Shinya Yamamoto, 2007, European urology.

Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

S. Urakami, Y. Yasuda, Shinya Yamamoto, 2013, International Journal of Clinical Oncology.

Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel.

S. Urakami, Y. Yasuda, N. Numao, 2011, Urology.

Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer

S. Kawakami, Shinya Yamamoto, I. Fukui, 2006, International Journal of Clinical Oncology.

Muscle-invasive urothelial carcinoma of the bladder.

M. Benson, S. Malkowicz, V. Pansadoro, 2007, Urology.

Clinical outcome of patients with pancreatic metastases from renal cell cancer

Y. Ishikawa, Y. Fujii, S. Urakami, 2015, BMC Cancer.

Fate of patients undergoing pulmonary metastasectomy for metastatic urothelial carcinoma

V. Bilim, I. Sasagawa, Y. Kageyama, 2017 .

Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinoma.

Y. Fujii, S. Urakami, A. Yano, 2014, Urologic oncology.

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma

J. Yonese, I. Fukui, T. Tsukamoto, 2006, Cancer.

[Successful salvage chemotherapy with gemcitabine, etoposide and cisplatin for metastatic ureteral cancer: a case report].

J. Yonese, I. Fukui, T. Tsukamoto, 2002, Hinyokika kiyo. Acta urologica Japonica.

[Adjuvant chemotherapy following total cystectomy for invasive bladder cancer with bleomycin, vincristine and methotrexate].

I. Fukui, M. Katoh, S. Takeuchi, 1984, Hinyokika kiyo. Acta urologica Japonica.

Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor

Y. Ishikawa, Y. Seto, Y. Fujii, 2007, International Journal of Clinical Oncology.

Characteristics and Oncological Outcome of Clinical T3a Prostate Cancer Patients Undergoing Radical Prostatectomy in the Multi-Parametric MRI Era

Y. Ishikawa, N. Numao, H. Takeda, 2018 .

Significance of Bladder Neck Involvement on Progression in Superficial Bladder Cancer

K. Kihara, T. Tsujii, Y. Fujii, 1998, European Urology.

Effectiveness of adjuvant intermittent endocrine therapy following neoadjuvant endocrine therapy and external beam radiation therapy in men with locally advanced prostate cancer

Y. Ohashi, S. Naito, Kazuto Ito, 2005, The Prostate.

First-Line Combination Chemotherapy with Cisplatin, Etoposide and Ifosfamide for the Treatment of Disseminated Germ Cell Cancer: Re-Evaluation in the Granulocyte Colony-Stimulating Factor Era

Hajime Tanaka, Y. Fujii, S. Urakami, 2014, Chemotherapy.

Pembrolizumab for a patient with metastatic castration‐resistant prostate cancer with microsatellite instability‐high

N. Numao, Shinya Yamamoto, J. Yonese, 2020, IJU case reports.

Possible improvement of survival with use of zoledronic acid in patients with bone metastases from renal cell carcinoma

Y. Fujii, S. Urakami, Y. Yasuda, 2013, International Journal of Clinical Oncology.

Treatment outcome and prognostic factors in renal cell cancer patients with bone metastasis

S. Urakami, Shinya Yamamoto, J. Yonese, 2011, Clinical & Experimental Metastasis.

External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer

N. Numao, S. Ohde, Shinya Yamamoto, 2021, International Journal of Clinical Oncology.

Phase-1 study of abiraterone acetate in chemotherapy-naïve Japanese patients with castration-resistant prostate cancer

H. Akaza, K. Iizuka, I. Fukui, 2014, Cancer science.

Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate

T. Kijima, Y. Fujii, Y. Okubo, 2009, BJU international.

[A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors].

H. Akaza, I. Fukui, K. Tobisu, 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.

M. Oka, S. Saji, T. Taguchi, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Diagnostic performance and safety of a three‐dimensional 14‐core systematic biopsy method

K. Kihara, F. Koga, T. Kijima, 2015, BJU international.

Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan

N. Numao, Shinya Yamamoto, J. Yonese, 2020, Targeted Oncology.

Do testosterone levels have prognostic significance in patients with metastatic prostate cancer treated with combined androgen blockade?

Y. Fujii, Y. Yasuda, Shinya Yamamoto, 2015, International journal of urology : official journal of the Japanese Urological Association.

The serum level of the amino‐terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone

M. Koizumi, J. Yonese, I. Fukui, 2001, BJU international.

Diverse Fusion Patterns and Heterogeneous Clinicopathologic Features of Renal Cell Carcinoma With t(6;11) Translocation

Y. Ishikawa, M. Fujiwara, Y. Fujii, 2012, The American journal of surgical pathology.

Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline.

M. Nakane, K. Kage, I. Fukui, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].

I. Fukui, H. Oshima, T. Yamada, 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Studies on tissue blood-group antigens of superficial bladder cancer].

I. Fukui, R. Kamiyama, D. Ishiwata, 1984, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate cancer

Y. Fujii, S. Uehara, A. Yano, 2015, BMC Research Notes.

Favorable response to combination treatment of cimetidine, cyclooxygenase‐2 inhibitor and renin‐angiotensin system inhibitor in metastatic renal cell carcinoma: Report of three cases

K. Kihara, F. Koga, Y. Fujii, 2008, International journal of urology : official journal of the Japanese Urological Association.

[Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].

I. Fukui, T. Tsukamoto, N. Ishii, 2002, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Actinomycosis of urachal remnants.

I. Fukui, H. Oshima, R. Kamiyama, 1988, The Journal of urology.

Locally‐Confined Signet‐Ring Cell Carcinoma of the Prostate: A Case Report of a Long‐Term Survivor

K. Yoshimura, H. Maeda, I. Fukui, 1996, International journal of urology : official journal of the Japanese Urological Association.

[A case of spermatocytic seminoma].

K. Kihara, I. Fukui, R. Kamiyama, 1989, Gan no rinsho. Japan journal of cancer clinics.

Impact of C‐reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second‐line chemotherapy with gemcitabine, etoposide and cisplatin

S. Urakami, Y. Yasuda, Y. Okubo, 2012, BJU international.

Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry

Y. Ishikawa, M. Fujiwara, Y. Fujii, 2009, Clinical Cancer Research.

Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.

I. Fukui, H. Ohshima, H. Sekine, 1996, The Journal of urology.

Efficacy and Safety Profile of Enzalutamide for Japanese Patients with Castration-resistant Prostate Cancer.

Tatsuro Hayashi, Shinya Yamamoto, J. Yonese, 2016, Anticancer research.

Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer

Y. Fujii, S. Urakami, Shinya Yamamoto, 2013, Quality of Life Research.

Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy.

Y. Ishikawa, Y. Fujii, S. Urakami, 2012, Japanese journal of clinical oncology.

Pyogenic granuloma of the glans penis.

Y. Ishikawa, J. Yonese, I. Fukui, 1998, British journal of urology.

[A case of inflammatory myofibroblastic tumor of the urinary bladder finally diagnosed by anaplastic lymphoma kinase (ALK) immunostaining].

Y. Ishikawa, N. Inoshita, A. Kono, 2006, Hinyokika kiyo. Acta urologica Japonica.

[Consecutive evaluation of vesico-urethral function in patients undergoing radical retropubic prostatectomy].

I. Fukui, H. Oshima, H. Nagamatsu, 1994, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Urodynamic evaluation of patients undergoing radical prostatectomy. A preliminary report].

I. Fukui, S. Kitahara, H. Oshima, 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Successful use of endoscopic argon plasma coagulation for hemorrhagic radiation cystitis: a case report.

Tatsuro Hayashi, M. Igarashi, J. Fujisaki, 2014, Japanese journal of clinical oncology.

First‐line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice

Yasuhisa Fujii, Hajime Tanaka, N. Numao, 2021, International journal of urology : official journal of the Japanese Urological Association.

Cisplatin, Gemcitabine, and Paclitaxel as a Salvage Second-Line Therapy for Metastatic Germ-Cell Cancer.

N. Numao, H. Takeda, Tatsuro Hayashi, 2020, Clinical genitourinary cancer.

Phase II Study of Second-line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma

N. Numao, Shinya Yamamoto, J. Yonese, 2020, AntiCancer Research.

Inhibitory effect of testosterone on gap junctional intercellular communication of human transitional cell carcinoma cell lines.

K. Kihara, I. Fukui, H. Oshima, 1990, Cancer research.

[A study of prevention of ejaculatory disturbance after retroperitoneal lymph node dissection in testicular tumor].

K. Kihara, I. Fukui, H. Oshima, 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Treatment results of radical nephrectomy for relatively confined small renal cell carcinoma--translumbar versus transabdominal approach].

Y. Kageyama, I. Fukui, S. Kitahara, 1994, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Significance of ipsilateral adrenalectomy in surgery for renal cell carcinoma].

T. Kijima, Y. Fujii, Y. Okubo, 2010, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes.

I. Fukui, N. Sakamoto, K. Takebe, 1983, The Tohoku journal of experimental medicine.

[Macroscopic tumor thrombus in renal cell carcinoma].

Y. Tachibana, I. Fukui, H. Oshima, 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Successful extirpation of the right renal cell carcinoma together with the inferior vena cava: report of a case and review of literature].

I. Fukui, H. Afuso, R. Hatano, 1983, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival.

K. Kihara, Y. Kageyama, S. Kawakami, 2001, Urology.

History of malignancy is a predictor of prostate cancer detection: Incorporation into a pre‐biopsy nomogram

K. Kihara, F. Koga, Y. Fujii, 2008, International journal of urology : official journal of the Japanese Urological Association.

Clinical outcome of patients with pancreatic metastases from renal cell cancer

Y. Ishikawa, Y. Fujii, S. Urakami, 2015, BMC Cancer.

Intraoperative Only versus Extended Duration Use of Antimicrobial Prophylaxis for Infectious Complications in Radical Cystectomy with Intestinal Urinary Diversion

S. Uehara, N. Numao, Shinya Yamamoto, 2020, Urologia Internationalis.

Carcinoma in situ of the urinary bladder. Effect of associated neoplastic lesions on clinical course and treatment

I. Fukui, H. Oshima, Takashi Yamada, 1987, Cancer.

Successful therapy of a malignant phyllodes tumor of the prostate after postoperative local failure.

Y. Ishikawa, J. Yonese, I. Fukui, 2006, Urology.

FDG PET imaging in a patient with primary seminoma of the prostate.

M. Koyama, I. Fukui, K. Hayasaka, 2011, Clinical nuclear medicine.

[Results of radiation therapy of bladder tumors: with special reference to the significance of preoperative irradiation].

I. Fukui, H. Shibuya, J. Horiuchi, 1985, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Clinicopathological study of upper urinary tract tumors associated with bladder tumors.

K. Kihara, I. Fukui, K. Ishizaka, 1991, European urology.

In vivo staining test with methylene blue for bladder cancer.

K. Igarashi, I. Fukui, I Fukui, 1983, The Journal of urology.

Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.

Y. Ishikawa, K. Kihara, M. Yokoyama, 2007, European urology.

A novel equation and nomogram including body weight for estimating prostate volumes in men with biopsy-proven benign prostatic hyperplasia.

K. Kihara, F. Koga, Y. Fujii, 2012, Asian journal of andrology.

Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma

T. Tsujii, S. Kawakami, J. Yonese, 2007, International Journal of Clinical Oncology.

Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: A case report

T. Kijima, Y. Fujii, Y. Okubo, 2008, International journal of urology : official journal of the Japanese Urological Association.

Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer

Y. Ishikawa, K. Kihara, N. Numao, 2007, International journal of urology : official journal of the Japanese Urological Association.

Evaluation of the RENAL Nephrometry Scoring System in Adopting Nephron-Sparing Surgery for cT1 Renal Cancer

S. Urakami, Y. Yasuda, Shinya Yamamoto, 2012, Urologia Internationalis.

Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrosp

Hajime Tanaka, S. Yoshida, M. Yokoyama, 2022, Japanese journal of clinical oncology.

Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients.

Y. Ishikawa, K. Kihara, J. Kumagai, 2008, Urology.

[Cytology of percutaneous aspiration biopsy of renal angiomyolipoma: a study of 4 cases].

K. Kihara, Y. Tachibana, I. Fukui, 1987, Hinyokika kiyo. Acta urologica Japonica.

[Multiple urothelial cancers accompanied by acquired cystic disease of the kidney in a long-term hemodialysis patient].

S. Kawakami, I. Fukui, H. Oshima, 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Clinical Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Upper Tract Urothelial Carcinoma: Impact on Detection of Metastases and Patient Management

Yasuhisa Fujii, K. Kihara, Hajime Tanaka, 2015, Urologia Internationalis.

Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer.

Takeshi Yuasa, Shinya Yamamoto, M. Kodaira, 2011, Urology.

[Low dose CVD chemotherapy as a tumor dormancy therapy for extra-adrenal malignant pheochromocytoma: a case report].

Y. Ishikawa, Y. Hasegawa, J. Yonese, 2001, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

A novel technique to prevent postradical retropubic prostatectomy inguinal hernia: the processus vaginalis transection method.

T. Kijima, Y. Fujii, S. Kawakami, 2009, Urology.

[Clinical study of renal cell carcinoma with brain metastasis].

S. Kawakami, K. Yoshimura, I. Fukui, 1995, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[Mesonephric adenocarcinoma arising in the female urethral diverticulum].

K. Yoshimura, H. Maeda, Y. Okubo, 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

A novel repeat biopsy nomogram based on three-dimensional extended biopsy.

K. Kihara, J. Kumagai, F. Koga, 2011, Urology.

Body mass index influences prostate cancer risk at biopsy in Japanese men

K. Kihara, M. Yokoyama, Y. Matsuoka, 2013, International journal of urology : official journal of the Japanese Urological Association.

Denosumab: a new option in the treatment of bone metastases from urological cancers

Shinya Yamamoto, S. Urakami, J. Yonese, 2012, OncoTargets and therapy.

Prophylactic Antibiotics for Urological Procedures

D. Jacqmin, P. Joseph, P. Alken, 1999, European Urology.

Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.

Kazunori Kihara, Yasuhisa Fujii, Tetsuo Okuno, 2007, European urology.

Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery

Hajime Tanaka, Y. Fujii, S. Urakami, 2015, International Journal of Clinical Oncology.

Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection.

Y. Ishikawa, Y. Fujii, S. Kawakami, 2009, Japanese journal of clinical oncology.

Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.

K. Kihara, J. Kumagai, Y. Fujii, 2009, The Journal of urology.

Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer

T. Kim, J. Yonese, I. Fukui, 2001, Cancer Chemotherapy and Pharmacology.

Long-term Oncological Outcome and Risk Stratiﬁcation in Men with High-risk Prostate Cancer Treated with Radical Prostatectomy

Y. Ishikawa, Y. Fujii, S. Urakami, 2012 .

[Renal hemangiopericytoma: report of a case].

Y. Ishikawa, K. Yoshimura, H. Maeda, 1998, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer.

Y. Ishikawa, Y. Fujii, S. Kawakami, 2008, Urology.

Equivalent efficacy of mitomycin C plus doxorubicin instillation to bacillus Calmette‐Guerin therapy for carcinoma in situ of the bladder

K. Ohya, K. Igarashi, I. Fukui, 2001, International journal of urology : official journal of the Japanese Urological Association.

Multiple primary malignant neoplasms associated with prostate cancer in 312 consecutive cases.

S. Kawakami, I. Fukui, T. Kawai, 1997, Urologia internationalis.

Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer

Y. Fujii, S. Urakami, Y. Kageyama, 2020, AntiCancer Research.

Improving accuracy, reliability, and efficiency of the RENAL nephrometry score with 3D reconstructed virtual imaging.

N. Numao, Tatsuya Yamamoto, Shinya Yamamoto, 2022, Urology.

Combination chemotherapy of ifosfamide, 5‐fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy

Y. Fujii, S. Kawakami, Y. Okubo, 2008, International journal of urology : official journal of the Japanese Urological Association.

Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors

K. Kihara, I. Fukui, H. Oshima, 2004, Cancer Chemotherapy and Pharmacology.

Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response

K. Kihara, Y. Tachibana, I. Fukui, 2004, Cancer Chemotherapy and Pharmacology.

Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder: a longer followup result.

I. Fukui, H. Ohshima, H. Sekine, 1994, The Journal of urology.

Intravesical combination chemotherapy with mitomycin C and doxorubicin for carcinoma in situ of the bladder.

K. Kihara, I. Fukui, S. Takeuchi, 1989, The Journal of urology.

The relationship of ABH(O) blood group antigen expression in intraepithelial dysplastic lesions to clinicopathologic properties of associated transitional cell carcinoma of the bladder

I. Fukui, Tsuyoshi Kobayashi, Takashi Yamada, 1991, Cancer.

Lymphovascular invasion is an independent predictor of prostate‐specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer

Y. Ishikawa, T. Kijima, Y. Fujii, 2008, International journal of urology : official journal of the Japanese Urological Association.

[Allergic reaction to CDDP: report of 4 cases].

T. Kasamatsu, Y. Tachibana, I. Fukui, 1984, Hinyokika kiyo. Acta urologica Japonica.

[Treatment results of VIP (etoposide, ifosfamide and cisplatin) chemotherapy as a first-line therapy in metastatic germ cell tumors].

J. Yonese, I. Fukui, S. Kitsukawa, 2000, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer

Y. Fujii, S. Kawakami, Y. Okubo, 2008, BJU international.

Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era

Y. Ishikawa, Hajime Tanaka, Y. Fujii, 2015, International Journal of Clinical Oncology.

Long-term oncological outcome in men with T3 prostate cancer: radical prostatectomy versus external-beam radiation therapy at a single institution

Y. Ishikawa, Y. Fujii, S. Urakami, 2014, International Journal of Clinical Oncology.

Pathological Predictors of utcome rognostic Significance of Cancer Volume nvolving Seminal Vesicles in Patients With T 3 bpN 0 Prostate Cancer

Y. Ishikawa, Y. Fujii, S. Kawakami, 2022 .

Young age as favorable prognostic factor for cancer-specific survival in localized renal cell carcinoma.

K. Kihara, T. Tsujii, F. Koga, 2011, Urology.

[Multiple synchronous primary malignant tumors of fibrosarcoma and squamous cell carcinoma in the urinary bladder: a case report].

Y. Ishikawa, I. Fukui, N. Aoki, 2002, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Three‐dimensional 26‐core biopsy‐based patient selection criteria for nerve‐sparing radical prostatectomy

Y. Ishikawa, K. Kihara, F. Koga, 2008, International journal of urology : official journal of the Japanese Urological Association.

Changing expression of ABH blood group and cryptic T‐antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression

I. Fukui, H. Oshima, M. Yokokawa, 1988, Cancer.

A study of prognosis and clinicopathology of bladder cancer to blood group type of host patients in Japan.

I. Fukui, H. Oshima, T. Yamada, 1993, Scandinavian Journal of Urology and Nephrology.

Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer

J. Yonese, I. Fukui, T. Yuasa, 2011, Cancer science.

[Discriminant analysis of quantification theory on prognostic factors of chemotherapeutic effects on advanced testicular cancer. East Japan Testicular Tumor Study Group].

H. Akaza, I. Fukui, K. Tobisu, 1990, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[A study of intercellular communication of human transitional cell carcinoma cell lines].

K. Kihara, Y. Kageyama, I. Fukui, 1989, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.

M. Koizumi, J. Yonese, I. Fukui, 2002, The Journal of urology.

First-line chemotherapy with gemcitabine, etoposide, and cisplatin in combined-multimodality treatment for patients with advanced urothelial carcinoma.

Y. Fujii, A. Yano, Shinya Yamamoto, 2013, Journal of Clinical Oncology.

Molecular Targeted Therapies for Patients with Metastatic Renal Cell Cancer

Y. Fujii, J. Yonese, I. Fukui, 2013 .

Antegrade radical retropubic prostatectomy with preliminary ligation of vascular pedicles in 614 consecutive patients.

Y. Ishikawa, Shinya Yamamoto, S. Kawakami, 2007, Japanese Journal of Clinical Oncology.

Preliminary ligation of vascular pedicles in male radical cystectomy.

J. Yonese, I. Fukui, T. Kawai, 1997, British journal of urology.

[Successful multidisciplinary treatment for bladder cancer with priapism. A case report].

Y. Ishikawa, J. Yonese, I. Fukui, 1998, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer

K. Kihara, Y. Fujii, Y. Kageyama, 2006, International Journal of Clinical Oncology.

Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.

M. Kodaira, T. Saotome, K. Takeuchi, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

5-fluorouracil and allopurinol combined with recombinant interferon-alpha 2b in the treatment of patients with advanced prostate cancer: a phase I/II study.

A. Schned, M. Ernstoff, R. Amdur, 1996, The Journal of urology.

Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL.

K. Kihara, F. Koga, Y. Fujii, 2012, Urology.

Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer

J. Yonese, I. Fukui, T. Yuasa, 2011, Cancer science.

Body mass index influences prostate cancer risk at biopsy in Japanese men

K. Kihara, M. Yokoyama, Y. Matsuoka, 2013, International journal of urology : official journal of the Japanese Urological Association.

[Carcinoma in situ of the penis rapidly progressing after carbon dioxide laser treatment].

Y. Ishikawa, Y. Hasegawa, J. Yonese, 2002, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Profound bicalutamide withdrawal syndrome in a hormone‐refractory T4N1 prostate cancer permitting both salvage radiotherapy and cessation of hormonal therapy

S. Kawakami, I. Fukui, H. Takeshita, 2009, International journal of urology : official journal of the Japanese Urological Association.